Table 3.
Comparison of AQLQ test results in patients with asthma before and after the intervention
| Variables | Probiotic group (n = 17) | Placebo group (n = 18) | Cohen’s d (95% CI) | p |
|---|---|---|---|---|
| ACT | ||||
| Baseline | 15.41 ± 4.5 | 14.67 ± 2.3 | 0.06 (−0.61 to 0.72) | 0.41t |
| 2nd consultation | 18.65 ± 4.2 | 16.22 ± 4.79 | 0.53 (−0.15 to 1.20) | 0.13t |
| Cohen’s d (95% CI) | −0.73 (−1.42 to −0.03) | −0.41 (−1.08 to 0.26) | ||
| p | 0.0001tp | 0.051tp | ||
| AQLQ | ||||
| Baseline | 2.4 ± 0.96 | 2.63 ± 0.83 | −0.06 (−0.73 to 0.63) | 0.50t |
| 2nd consultation | 3.6 ± 0.98 | 2.87 ± 0.80 | 0.79 (0.10 to 1.48) | 0.01t |
| Cohen’s d (95% CI) | −1.21 (−1.94 to −0.48) | −0.29 (−0.94 to 0.37) | ||
| p | 0.0001tp | 0.06tp | ||
T Student’s t and W the Wilcoxon Mann-Whitney tests for independent samples and Tp Student’s t and Wp the Wilcoxon tests for paired samples.
FEV1 forced expiratory volume in one second, FVC orced vital capacity,